The tweet was deleted by the author.
But we saved everything 🙂.
Twist Bioscience is reflecting on the first half of 2026 with a focus on sentiment and outlook.
The company referenced a 'vibe check' in a tweet and invited followers to choose which feeling describes the year so far. Details are being clarified.
View post on X Loading...
TWST is trading at $102.88, well above its MA-20 at $81.96, MA-50 at $68.08, and MA-200 at $45.59. This setup confirms persistent bullish momentum across short-, medium-, and long-term timeframes. The Ichimoku Kijun sits at $80.39, acting as immediate support under current price action. Near-term support is clustered at the Kijun ($80.39), with key support at MA-50 ($68.08). The first resistance area is near MA-5/MA-10 ($97.82–$91.46), but with price extended, key resistance is marked by this week’s high at $104.11.
Momentum signals on D1 such as MACD and ADX support continued upside, with both indicating a buy bias. However, RSI at 79.00, CCI at 137.13, Stoch RSI at 98.24, and BBP at 13.68 all show clear overbought conditions, warning of short-term exhaustion as buyers strongly dominate the session. The Awesome Oscillator also supports the prevailing trend. TWST has risen $3.04 (3.04%) over the past week, trading at $102.88 versus $99.84 a week ago. The current price is at the very top of the weekly range, and weekly volatility stands at 21.77%. The stock is consolidating near resistance after a strong rally, with momentum confirmed but overbought signals flashing caution.
Looking ahead, the projected price range for the coming week is $97.00 to $106.00, reflecting the sharp uptrend and recent high volatility but normalized to keep within 8% of the current price. This range is near the 52-week high of $104.11 and far above the annual low of $23.30. On the W1 chart, all key momentum indicators (RSI, ADX, MACD, MA-50) are bullish. This implies a very high probability (more than 80%) of price increase, while the odds of a reversal are very low. The baseline scenario anticipates price consolidation between $97.00 and $106.00. In the bullish case, a sustained breakout above $106.00 could open room toward new highs as buying pressure resumes. In a bearish scenario, a pullback below $97.00 may follow if overbought pressures trigger profit-taking, but multiple layers of support remain in place.
Previously it was reported that Twist Bioscience was exhibiting strong bullish momentum, with technical analysis pointing toward continued upside. This article adds a new dimension by reassessing the prevailing scenario for TWST, highlighting a key level that traders should monitor as market conditions develop.